These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4652160)

  • 1. [Clinical therapy of ischemic heart diseases using Rocornal Trapymin].
    Libuda H
    Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1208-10. PubMed ID: 4652160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies with Rocornal (trapymin)--a new cardioactive substance].
    Dittrich P; Fiehring H; Brunn F; Rothe R; Lauten A
    Dtsch Gesundheitsw; 1971 Sep; 26(36):1684-8. PubMed ID: 5116099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of 6-methyl-7-diethylamino-s-triazolo-(1,5-a) pyrimidine (Trapymin, Rocornal), a new compound with vasodilative effects].
    Füller H; Hauschild F; Modersohn D; Thomas E
    Pharmazie; 1971 Sep; 26(9):554-62. PubMed ID: 5137075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of mechanocardiographic and spiroergometric examinations following trapymin administration to healthy persons].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Sziegoleit W; Enke H
    Z Gesamte Inn Med; 1972 Sep; 27(18):782-5. PubMed ID: 4634252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of rocornal in emergencies].
    Weser C; Müller JH; Henkel C
    Dtsch Gesundheitsw; 1972 May; 27(18):830-4. PubMed ID: 5037372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of nifedipine and a minoxidil-like arterial vasodilator on myocardial ischemia under dynamic electrocardiographic monitoring].
    Strozzi C; Cocco G; Tasini MT; Padula A; Rizzo A; Alfiero R; Urso L; Montanari L; Portaluppi F
    Clin Ter; 1986 Jul; 118(1):9-12. PubMed ID: 3742977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Rocornal (trapymin) on heart- and circulatory function].
    Wallrabe D; Thiel H
    Dtsch Gesundheitsw; 1972 Sep; 27(37):1739-44. PubMed ID: 4635864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ustimon (ST 7090) in the treatment of coronary disease].
    Chrzanowski W; Pracka H
    Wiad Lek; 1967 Jun; 20(12):1159-61. PubMed ID: 6056177
    [No Abstract]   [Full Text] [Related]  

  • 9. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of irrigor as a drug improving the coronary blood flow].
    Bolińska H; Kaluzna J
    Wiad Lek; 1970 Sep; 23(17):1491-3. PubMed ID: 5472083
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical studies with a new coronary and heart-active substance].
    Moll A; Petzel H
    Z Kreislaufforsch; 1967 Jan; 56(1):46-58. PubMed ID: 5595482
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary reserve and cardiac output of patients with ischemic heart disease after measured exercise therapy as well as additional treatment with hexobendine].
    Drews A
    Arzneimittelforschung; 1968 Aug; 18(8):1084-94. PubMed ID: 5755843
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of trapymin (Rocornal)].
    Preifer S; Borchert HH; Bornschein I; Meyer-Kollar R
    Pharmazie; 1972 Dec; 27(12):749-52. PubMed ID: 4664645
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Clinical evaluation of perhexiline maleate in the treatment of chronic cardiac arrhythmias of patients with coronary heart disease.
    Sukerman M
    Postgrad Med J; 1973 Apr; 49():Suppl 3:46-52. PubMed ID: 4587032
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.